Analyst Ratings for ISIS Pharmaceuticals (isis)

isis Rating Summary

isis Price Target Summary

* Over Last 12-Mos
  |   Expand Research on isis
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $54.17 (+6.3%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
9/26/2014 Leerink Swann New Coverage Market Perform
(N/A)
40.00
(N/A)
40.30 50.94 26.4% Details
8/12/2014 Laidlaw New Coverage Buy
(N/A)
52.00
(N/A)
34.79 50.94 46.42% Details
Like ISIS Ratings? Also take a look at SNY, SAN, GSK, BIIB

ISIS Ratings News